These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 15570010)

  • 1. In vitro effects of the BH3 mimetic, (-)-gossypol, on head and neck squamous cell carcinoma cells.
    Oliver CL; Bauer JA; Wolter KG; Ubell ML; Narayan A; O'Connell KM; Fisher SG; Wang S; Wu X; Ji M; Carey TE; Bradford CR
    Clin Cancer Res; 2004 Nov; 10(22):7757-63. PubMed ID: 15570010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of cisplatin resistance with a BH3 mimetic, (-)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xL.
    Bauer JA; Trask DK; Kumar B; Los G; Castro J; Lee JS; Chen J; Wang S; Bradford CR; Carey TE
    Mol Cancer Ther; 2005 Jul; 4(7):1096-104. PubMed ID: 16020667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting apoptosis to overcome cisplatin resistance: a translational study in head and neck cancer.
    Bauer JA; Kumar B; Cordell KG; Prince ME; Tran HH; Wolf GT; Chepeha DB; Teknos TN; Wang S; Eisbruch A; Tsien CI; Urba SG; Worden FP; Lee J; Griffith KA; Taylor JM; D'Silva N; Wang SJ; Wolter KG; Henson B; Fisher SG; Carey TE; Bradford CR
    Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S106-8. PubMed ID: 17848273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.
    Meng Y; Tang W; Dai Y; Wu X; Liu M; Ji Q; Ji M; Pienta K; Lawrence T; Xu L
    Mol Cancer Ther; 2008 Jul; 7(7):2192-202. PubMed ID: 18645028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting antiapoptotic Bcl-2 family members with cell-permeable BH3 peptides induces apoptosis signaling and death in head and neck squamous cell carcinoma cells.
    Li R; Boehm AL; Miranda MB; Shangary S; Grandis JR; Johnson DE
    Neoplasia; 2007 Oct; 9(10):801-11. PubMed ID: 17971900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer.
    Zerp SF; Stoter TR; Hoebers FJ; van den Brekel MW; Dubbelman R; Kuipers GK; Lafleur MV; Slotman BJ; Verheij M
    Radiat Oncol; 2015 Jul; 10():158. PubMed ID: 26223311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas.
    Lee TL; Yeh J; Friedman J; Yan B; Yang X; Yeh NT; Van Waes C; Chen Z
    Int J Cancer; 2008 May; 122(9):1987-98. PubMed ID: 18172861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced cisplatin sensitivity of head and neck squamous cell carcinoma cell lines correlates with mutations affecting the COOH-terminal nuclear localization signal of p53.
    Mandic R; Schamberger CJ; Müller JF; Geyer M; Zhu L; Carey TE; Grénman R; Dünne AA; Werner JA
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6845-52. PubMed ID: 16203773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-XL, (-)-Gossypol, enhances biological effect of genistein against BxPC-3 human pancreatic cancer cell line.
    Mohammad RM; Wang S; Banerjee S; Wu X; Chen J; Sarkar FH
    Pancreas; 2005 Nov; 31(4):317-24. PubMed ID: 16258364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway.
    Wang D; Veena MS; Stevenson K; Tang C; Ho B; Suh JD; Duarte VM; Faull KF; Mehta K; Srivatsan ES; Wang MB
    Clin Cancer Res; 2008 Oct; 14(19):6228-36. PubMed ID: 18829502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (-)-gossypol inhibits growth and promotes apoptosis of human head and neck squamous cell carcinoma in vivo.
    Wolter KG; Wang SJ; Henson BS; Wang S; Griffith KA; Kumar B; Chen J; Carey TE; Bradford CR; D'Silva NJ
    Neoplasia; 2006 Mar; 8(3):163-72. PubMed ID: 16611409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-xL inhibits p53- but not apoptin-induced apoptosis in head and neck squamous cell carcinoma cell line.
    Schoop RA; Kooistra K; Baatenburg De Jong RJ; Noteborn MH
    Int J Cancer; 2004 Mar; 109(1):38-42. PubMed ID: 14735465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of BH3 mimetics as a combination therapy with irradiation in head and neck squamous cell carcinoma.
    Korelin K; Oostveen M; Wahbi W; Ianevski F; Cavalcante B; Turunen L; Belevich I; Al-Samadi A; Salo T
    Biomed Pharmacother; 2024 Jun; 175():116719. PubMed ID: 38749173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin-dependent kinase inhibitor (roscovitine) suppresses growth and induces apoptosis by regulating Bcl-x in head and neck squamous cell carcinoma cells.
    Mihara M; Shintani S; Kiyota A; Matsumura T; Wong DT
    Int J Oncol; 2002 Jul; 21(1):95-101. PubMed ID: 12063555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo.
    Lin J; Wu Y; Yang D; Zhao Y
    Oncol Rep; 2013 Aug; 30(2):731-8. PubMed ID: 23708869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance.
    Liu S; Ren B; Gao H; Liao S; Zhai YX; Li S; Su XJ; Jin P; Stroncek D; Xu Z; Zeng Q; Li Y
    J Transl Med; 2017 Sep; 15(1):189. PubMed ID: 28877725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers.
    Sharma H; Sen S; Mathur M; Bahadur S; Singh N
    Head Neck; 2004 Aug; 26(8):733-40. PubMed ID: 15287041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (±)-Gossypol induces apoptosis and autophagy in head and neck carcinoma cell lines and inhibits the growth of transplanted salivary gland cancer cells in BALB/c mice.
    Benvenuto M; Mattera R; Masuelli L; Taffera G; Andracchio O; Tresoldi I; Lido P; Giganti MG; Godos J; Modesti A; Bei R
    Int J Food Sci Nutr; 2017 May; 68(3):298-312. PubMed ID: 27670669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death.
    Frederick MJ; Holton PR; Hudson M; Wang M; Clayman GL
    Clin Cancer Res; 1999 Feb; 5(2):361-9. PubMed ID: 10037186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence and helicity requirements for the proapoptotic activity of Bax BH3 peptides.
    Shangary S; Oliver CL; Tillman TS; Cascio M; Johnson DE
    Mol Cancer Ther; 2004 Nov; 3(11):1343-54. PubMed ID: 15542773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.